Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03633006 · ClinicalTrials.gov registry record
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
A clinical trial of Lung Cancer (Diagnosis), sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 3,298
- Enrollment target
- 20
- Study locations
NCT03633006 is a study of Lung Cancer (Diagnosis) that has completed, run by Exact Sciences Corporation. The registered enrollment target is 3,298 participants, below the 4,032-participant average among 6 other Lung Cancer (Diagnosis) trials with a reported enrollment target (18% lower). The trial reports 20 study locations across 4 states.
The verdict
NCT03633006, a study of Lung Cancer (Diagnosis), has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 3,298 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung. Subjects will be men and women, 35 years of age and older, with a CT confirmed nodule measuring 6-30 mm.
Conditions Studied
Interventions
- OTHER Blood Sample Collection
Study Locations (20)
Florida
- American Research Institute, Inc - Cutler Bay
- International Research Partners, LLC - Doral
- Jupiter Medical Center - Jupiter
- Pulmonary Disease Specialists - Kissimmee
- Medical Research of Central Florida, LLC - Leesburg
- Future Clinical Research - Miami
- University of Miami Miller School of Medicine - Miami
- Orcinova AMS Research - Miami
- Sunrise Research Institute, Inc - Miami
- American Research Medical Group - Miami
- Health and Life Research Institute, LLC - Miami
- Care Research Center - Miami
- Clinical Trials of Florida, LLC - Miami
- AMPM research Clinic - Miami Gardens
California
- Newport NativeMD - Newport Beach
- Palmtree Clinical Research, Inc - Palm Springs
- Palo Alto Veterans Health Care - Palo Alto
- Premier Medical Group - Upland
Alabama
- Achieve Clinical Research - Birmingham
Arizona
- Phoenix Medical Group - Peoria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,298 participants |
| Start Date | 2016-04-11 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03633006
The ClinicalTrials.gov registry entry for NCT03633006 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,298 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,032-participant average among 6 other Lung Cancer (Diagnosis) trials with a reported enrollment target (18% lower). The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which Blood Sample Collection is the first listed.
NCT03633006 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT03633006 about?
NCT03633006 is a clinical study titled "Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer". The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung. Subjects will be men and women, 35 years of age and older, with a CT confirmed nodule measuring 6-30 mm.
What is the current status of trial NCT03633006?
This trial is currently completed. The enrollment target is 3,298 participants. The study started on 2016-04-11. Estimated completion is 2020-12-31.
What conditions does trial NCT03633006 study?
This clinical trial studies the following conditions: Lung Cancer (Diagnosis).
What interventions are being tested in trial NCT03633006?
The interventions under investigation include: Blood Sample Collection (OTHER).
Who is sponsoring clinical trial NCT03633006?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03633006 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
RECRUITING · NA
-
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
RECRUITING · NA
-
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
RECRUITING
-
Telehealth Collaborative Care Model (CoCM) in Lung Cancer
RECRUITING · NA
-
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RECRUITING
-
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.